Market cap
$3 Mln
Revenue (TTM)
$8 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 14.13 | -77.15 | -56.41 | 3.78 | -9.59 |
| EBIT | -29.54 | -33.83 | -48.65 | -480.05 | -254.94 |
| Net Profit | -137.17 | -175.21 | -111.18 | -428.46 | -270.33 |
| EPS | -92.74 | -32.05 | -36.42 | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -223.78 | -127.14 | -732.02 | -414.33 | -33.23 |
| Net Margin
| -- | -- | -1,100.30 | -- | -- |
| Return on equity
| 1,128.95 | 635.00 | -- | 3,545.19 | -357.65 |
| Return on Capital
| -80.78 | -81.84 | -- | -458.64 | -46.26 |
| Return on Assets
| -655.36 | -422.82 | -130.76 | -230.71 | -23.78 |
| Debt to Equity (x)
| -- | -- | 0.00 | -1.99 | 3.73 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
-458.64
|
-46.26
|
262.57
|
-109.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
3,545.19
|
-357.65
|
199.31
|
-145.76
|
|
Peer Median
|
26.56
|
--
|
--
|
--
|
--
|
ROA
-130.76
Lower than Peers by 138.69
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-130.76
|
-230.71
|
-23.78
|
-1,711.58
|
-95.17
|
|
Peer Median
|
7.92
|
--
|
--
|
--
|
--
|
EBIT Margin
-732.02
Lower than Peers by 749.73
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-732.02
|
-414.33
|
-33.23
|
--
|
-7.49
|
|
Peer Median
|
17.71
|
--
|
--
|
--
|
--
|
Net Margin
-1,100.30
Lower than Peers by 1,118.70
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-1,100.30
|
-433.95
|
-37.82
|
--
|
-8.37
|
|
Peer Median
|
18.40
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-56.41
Lower than Peers by 69.09
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-56.41
|
0.29
|
--
|
-1.00
|
2.31
|
|
Peer Median
|
12.68
|
--
|
--
|
--
|
--
|
EBIT Growth
-48.65
Lower than Peers by 69.81
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-48.65
|
-1,504.96
|
--
|
--
|
53.58
|
|
Peer Median
|
21.17
|
--
|
--
|
--
|
--
|
Net Profit Growth
-111.18
Lower than Peers by 137.42
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-111.18
|
-1,377.12
|
-136.77
|
-5.54
|
33.29
|
|
Peer Median
|
26.24
|
--
|
--
|
--
|
--
|
EPS Growth
-36.42
Lower than Peers by 76.75
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-36.42
|
-9.81
|
-1.13
|
--
|
--
|
|
Peer Median
|
40.34
|
--
|
--
|
--
|
--
|
Book Value Growth
-1,133.81
Lower than Peers by 1,147.75
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-1,133.81
|
--
|
--
|
--
|
--
|
|
Peer Median
|
13.94
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
-1.99
|
3.73
|
-0.24
|
--
|
|
Peer Median
|
0.18
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-1.01
|
-0.94
|
1.86
|
-0.12
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.14
Lower than Peers by 1.50
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
0.14
|
0.09
|
0.40
|
0.12
|
--
|
|
Peer Median
|
1.64
|
--
|
--
|
--
|
--
|
Quick Ratio
0.10
Lower than Peers by 1.53
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
0.10
|
0.04
|
0.15
|
0.12
|
--
|
|
Peer Median
|
1.64
|
--
|
--
|
--
|
--
|
Interest Coverage
-13.87
Lower than Peers by 31.26
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
-13.87
|
-21.11
|
-7.25
|
--
|
-8.55
|
|
Peer Median
|
17.38
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
14.96
Higher than Peers by 4.05
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
14.96
|
4.87
|
20.66
|
--
|
--
|
|
Peer Median
|
10.91
|
--
|
--
|
--
|
--
|
Asset Turnover
0.12
Lower than Peers by 0.39
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
0.12
|
0.53
|
0.63
|
--
|
11.37
|
|
Peer Median
|
0.51
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
38.21
|
41.13
|
--
|
10.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
61.80
|
106.25
|
--
|
0.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
99.83
|
82.30
|
--
|
3.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
0.18
|
65.08
|
--
|
8.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
--
|
--
|
-1.68
|
--
|
|
Peer Median
|
21.76
|
--
|
--
|
--
|
--
|
Price / Book Value
1.81
Lower than Peers by 3.17
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
1.81
|
--
|
--
|
-1.68
|
--
|
|
Peer Median
|
4.98
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
--
|
--
|
--
|
-1.93
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
3
Lower than Peers by 4,697
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
|
3
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4,700
|
--
|
--
|
--
|
--
|